OptimizeRx CorporationOPRXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank95
3Y CAGR+85.3%
5Y CAGR+0.9%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+85.3%/yr
Quarterly compound
5Y CAGR
+0.9%/yr
Recent acceleration
Percentile
P95
Near historical high
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025575.00%
Q3 2025-51.69%
Q2 2025169.00%
Q1 2025-2900.00%
Q4 202499.20%
Q3 2024-127.27%
Q2 202442.11%
Q1 2024-65.22%
Q4 2023-35.29%
Q3 202329.17%
Q2 202335.14%
Q1 2023-1932.97%
Q4 202290.42%
Q3 20229.52%
Q2 20220.00%
Q1 2022-694.90%
Q4 20211434.78%
Q3 2021-88.50%
Q2 2021150.00%
Q1 2021-144.44%
Q4 2020550.00%
Q3 202072.79%
Q2 202051.00%
Q1 2020-7.14%
Q4 2019-27.27%
Q3 2019-466.67%
Q2 20195900.00%
Q1 2019105.49%
Q4 2018-145.50%
Q3 2018-33.33%
Q2 2018250.00%
Q1 201817.70%
Q4 201761.97%
Q3 2017-74.11%
Q2 201758.81%
Q1 2017-150.28%
Q4 2016-44.13%
Q3 201659.44%
Q2 2016-67.31%
Q1 201614.95%